Impact of Intravenous Iron in patients with heart failure and Iron Deficiency: an updated Meta-analysis of Randomized controlled trials
Haiming Wang, Yanhua Li, Jingjing Zhou, Jing Wang, Junjie Shao, Shuai Yue, Jiayue Li, Xinhong Guo, Ran Zhang · 2024
Read Impact of Intravenous Iron in patients with heart failure and Iron Deficiency: an updated Meta-analysis of Randomized controlled trials by Haiming Wang, Yanhua Li, Jingjing Zhou, Jing Wang, Junjie Shao, Shuai Yue, Jiayue Li, Xinhong Guo, Ran Zhang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11616113.txt.
Description
Haiming Wang and eight co-authors pooled trial results on iron given by vein to people with heart failure and low iron, in a review from twenty twenty-four. Past trials disagreed on whether the treatment cuts hospital stays and deaths, and on its safety. The team searched the main medical databases for trials that assigned patients by chance.
Eleven trials with more than six thousand patients met their rules. Iron by vein cut the combined risk of heart failure hospital stays and heart-related death. It also cut hospital stays on their own. Deaths from all causes, though, did not fall in a clear way. Longer treatment courses showed stronger gains, and side effects looked no worse overall.
Catalog record
| CREATOR | Haiming Wang, Yanhua Li, Jingjing Zhou, Jing Wang, Junjie Shao, Shuai Yue, Jiayue Li, Xinhong Guo, Ran Zhang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |